Core Viewpoint - The company, Taihe Co., Ltd. (301665), is set to gradually launch its proprietary product, cyhalofop-butyl, globally, with Brazil identified as a key market for expansion. This product is expected to become a new growth driver for the company and facilitate its strategic transition from "generic" to "proprietary," enhancing its global competitiveness [1]. Group 1 - The company will promote the proprietary product cyhalofop-butyl globally [1] - Brazil is a key market for the company's expansion efforts [1] - The product is anticipated to be a new performance growth point for the company [1] Group 2 - The strategic transition from "generic" to "proprietary" is a significant focus for the company [1] - The launch of the new product aims to enhance the company's global competitiveness [1]
泰禾股份：公司创制产品环丙氟虫胺将会在全球逐步推广上市